⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBIO News
iBio, Inc. Common Stock
ACTG to Make Three Presentations on HIV Cure and Aging with HIV at AIDS 2026
globenewswire.com
IBIO
GILD
Form 8-K
sec.gov
IBIO
Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight
prnewswire.com
PFE
ABBV
RMD
GSK
AZN
BNTX
INCY
IOVA
RGEN
MRK
LLY
IBIO
GILD
AMGN
JNJ
NVS
RIGL
BIIB
Form 8-K
sec.gov
IBIO
iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study
globenewswire.com
IBIO
Breakthrough Immorta Bio Study Collaboration With TAM Global Increases Life Span In Mice over 70% Using Novel Combination Senolytics
prnewswire.com
IBIO
iBio to Participate in Upcoming Healthcare Investor Conferences
globenewswire.com
IBIO
iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity
globenewswire.com
IBIO
InduPro Therapeutics Appoints Amanda J. Redig, MD, PhD, as Chief Medical Officer
businesswire.com
IBIO
Scientific Longevity Company Immorta Bio Appoints Former Ernst & Young Health Sciences Partner Howard Brooks to Corporate Board of Directors
prnewswire.com
IBIO